As of March 2026 Orchestra BioMed has a market cap of โน22.51 Billion. This makes Orchestra BioMed the world's 8206th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 1st, 2026 the market cap of Orchestra BioMed was reported to be: